Clinical Trial Update: Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the safety and efficacy of pimecrolimus cream 1% plus a topical corticosteroid in children aged 2-17 with severe atopic derma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus Cream 1% (pimecrolimus)
• Topical corticosteroid (unspecified)

Snippet

Sponsor: Novartis | Conditions: Dermatitis, Atopic | Phase 4 | Status: COMPLETED